Arizona State University
COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020
The pace of development for CRISPR-based infectious disease assays increased as the pandemic progress
Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project
The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients.
ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus
The test will be designed to run on a portable device that can ultimately be rolled out to point-of-need settings such as doctors' offices and workplaces.
Takara Bio, BioSyntagma Develop High-Throughput SARS-CoV-2 Detection Method
The new method uses Takara Bio's SmartChip PCR instrument, chips, and reagents to run 5,184 reactions per chip in less than 30 minutes.
The method can be used with isothermal amplification and paper-based readouts to detect infectious disease drug resistance in low-resource areas.
Jan 15, 2018
Nov 16, 2017
CRISPR Patents Must Be 'Reined In,' Experts Say
Mar 7, 2017
Apr 26, 2016
Sep 23, 2013
Mayo Clinic, Collaborators Establish Arizona Biobank
Jun 27, 2013